Article may be outdated

This article is 2 days old. Some details may have changed since publication.

The Conversation Africa·3 min read·medium

First mRNA flu shot approved by FDA bodes well for improving drugs of the future – though a few hurdles remain before mRNA can move beyond vaccines - The Conversation

L
Li Li
First mRNA flu shot approved by FDA bodes well for improving drugs of the future – though a few hurdles remain before mRNA can move beyond vaccines - The Conversation
AI Summary

The FDA's approval of the first mRNA flu vaccine marks a significant milestone in medical technology. While successful, researchers note that applying mRNA platforms to diseases beyond vaccines remains a complex challenge.

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic proces…

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealth

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in